Manish R Patel

22PUBLICATIONS

250CO-AUTHORS

Medical infection agents (incl. prions)Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (22)

Sort by Publication Date:

|May 18, 2026

Lipid Nanoparticle-encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ Plus Durvalumab Induces an Immunostimulatory Effect Within the Tumor Microenvironment in Patients with Advanced Solid Tumors.

|Jan 16, 2026

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study.

Krish Patel, Julie M Vose, Sunita D Nasta

|Dec 18, 2025

The Second Mitochondria-Derived Activator of Caspases Mimetic BI 891065 in Patients With Advanced Solid Tumors: Results From Two Phase I Studies.

Manish R Patel, Erika P Hamilton, Ben George

|Aug 22, 2025

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study.

Nirav N Shah, Pier Luigi Zinzani, Michael Wang

|Aug 11, 2025

Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1.

Richard D Baird, Begoña Bermejo de Las Heras, Manuel Ruiz-Borrego

|Jul 09, 2025

Single-Agent Divarasib in Patients With <i>KRAS G12C</i>-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.

Adrian G Sacher, Wilson H Miller, Manish R Patel

Pageof 4

Frequent Collaborators

Xuejing Wang

Erika P Hamilton

Chan Y Cheah

Susanna V Ulahannan

Todd M Bauer

Nirav N Shah

Pier Luigi Zinzani

David S Hong

Suzanne Jones

John M Burke

Frequent Collaborators

Xuejing Wang

Erika P Hamilton

Chan Y Cheah

Susanna V Ulahannan